Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Capital Work in Progress

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹238 Cr₹177 Cr₹181 Cr₹338 Cr₹188 Cr

What is the latest Capital Work in Progress ratio of GLAND PHARMA ?

The latest Capital Work in Progress ratio of GLAND PHARMA is ₹238 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹238 Cr
Mar2023₹177 Cr
Mar2022₹181 Cr
Mar2021₹338 Cr
Mar2020₹188 Cr

How is Capital Work in Progress of GLAND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹238 Cr
34.23
Mar2023 ₹177 Cr
-1.95
Mar2022 ₹181 Cr
-46.49
Mar2021 ₹338 Cr
79.24
Mar2020 ₹188 Cr -

Compare Capital Work in Progress of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,022.3 Cr -3.4% -11.2% 2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹453,486.0 Cr -0.6% 1.3% 65.7% Stock Analytics
DIVIS LABORATORIES ₹161,321.0 Cr -1.1% 11.4% 64% Stock Analytics
CIPLA ₹125,852.0 Cr -2.3% -6.8% 33.8% Stock Analytics
DR REDDYS LABORATORIES ₹111,799.0 Cr 1.5% 1% 22.9% Stock Analytics
ZYDUS LIFESCIENCES ₹102,726.0 Cr -4.2% -8.1% 72.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-3.4%

-11.2%

2.7%

SENSEX

-0.7%

-2.4%

22%


You may also like the below Video Courses